Safety and Immunogenicity of Ad26-vectored HIV Vaccine with Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-uninfected Adults: A Phase 1/2a Study

/in
Stieh, D. J., Barouch, D. H., Comeaux, C., Sarnecki, M., Stephenson, K. E., Walsh, S. R., Sawant, S., Heptinstall, J., Tomaras, G. D., Kublin, J. G., McElrath, M. J., Cohen, K. W., De Rosa, S. C., Alter, G., Ferrari, G., Montefiori, D., Mann, P., Nijs, S., Callewaert, K., Goepfert, P. A., … Tomaka, F. (2022). Safety and Immunogenicity of Ad26-vectored HIV Vaccine with Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-uninfected Adults: A Phase 1/2a Study. The Journal of infectious diseases, jiac445. Advance online publication. https://doi.org/10.1093/infdis/jiac445   [Article]